Results 201 to 210 of about 79,407 (254)

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Science, 2010
Anneke C Grobler, Cheryl Baxter, Leila E Mansoor   +2 more
exaly   +2 more sources

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Lancet, The, 2020
Kenneth Mayer, Peter L Anderson, Robert M Grant   +2 more
exaly   +2 more sources

Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

New England Journal of Medicine, 2015
Jeanne M Marrazzo, Gonasagrie Nair, Ariane van der Straten   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

Lancet HIV,the, 2020
BACKGROUND ADVANCE compared the efficacy and safety of two antiretroviral first-line combinations (dolutegravir combined with emtricitabine and either tenofovir disoproxil fumarate or tenofovir alafenamide), with a third regimen (efavirenz combined with ...
Simiso Sokhela, Bryony Simmons, Michelle A Moorhouse   +2 more
exaly   +2 more sources

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2013
Michael Martin, Manoj Leethochawalit, Craig W Hendrix   +2 more
exaly   +2 more sources

Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV

Annals of Internal Medicine, 2021
BACKGROUND Tenofovir-based antiretroviral therapy (ART) has become first-line in all major HIV treatment guidelines. Compared with tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF) has a favorable renal and bone safety profile, but ...
Bernard Surial, C. Mugglin, A. Calmy, M. Cavassini, H. Günthard, M. Stöckle, E. Bernasconi, P. Schmid, P. Tarr, H. Furrer, B. Ledergerber, G. Wandeler, A. Rauch   +12 more
semanticscholar   +1 more source

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B

Liver international (Print), 2022
We used real‐world data to evaluate the efficacy and safety of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in treatment‐naïve patients with CHB.
Jihye Lim, Won-Mook Choi, J. Shim, Danbi Lee, K. Kim, Y. Lim, H. Lee, J. Choi   +7 more
semanticscholar   +1 more source